Drugs fda zevalin marketing status discontinued?

Was FDA Zevalin marketing discontinued?

Yes. Zevalin (ibritumomab tiuxetan) was discontinued in the U.S. market; it is no longer marketed as a treatment. [1]

What does “discontinued” mean for patients trying to get Zevalin?

If a product is discontinued, it may be unavailable through standard distribution channels, and prescribers typically cannot order it through normal pathways. Patients are usually directed to alternative therapies based on the same target indication or to other available regimens. [1]

What alternatives are typically used when Zevalin is unavailable?

Zevalin is used in certain non-Hodgkin lymphoma settings (depending on prior therapy and disease characteristics). When it is not available, clinicians generally use other FDA-approved lymphoma treatments (for example, other antibody therapies and/or chemotherapy-based regimens), guided by the specific lymphoma subtype and line of therapy. The exact substitution depends on the patient’s diagnosis and treatment history. [1]

Why was Zevalin discontinued?

Public FDA-linked and industry information indicates the discontinuation is related to the product’s marketing availability status in the U.S., rather than a current active safety withdrawal in the cited FDA listing. [1]

Where can you check the current status of FDA-listed drugs like Zevalin?

The FDA’s official drug product listing/registry is the best place to verify whether a product is currently marketed or listed as discontinued. [1]

---

Sources

1. FDA Drug Shortages / Drug Product Information (Zevalin marketing status/discontinued listing)